Table 3

Summary of agreement and disagreement statistics for most prevalent pathogens and the report of at least one pathogen

Overall prevalenceOverall disagreementDifference (95% CI)*McNemar’s P valueOverall agreementUnadjusted kappa (95% CI)PABAK
At least one pathogen88.1%20.0%15.9% (11.8% to 20.1%)<0.000180.0%0.44 (0.34 to 0.53)0.60
Gram-positive cocci70.6%20.8%13.7% (9.4% to 18.0%)<0.000179.2%0.57 (0.50 to 0.65)0.58
Gram-negative bacilli36.7%15.4%9.4% (5.6% to 13.1%)<0.000184.6%0.63 (0.55 to 0.71)0.69
Enterobacteriaceae (including coliforms)26.6%12.9%5.8% (2.3% to 9.3%)0.001387.1%0.60 (0.50 to 0.70)0.74
Obligate anaerobes23.8%16.5%6.8% (2.9% to 10.8%)0.000883.5%0.38 (0.26 to 0.50)0.67
Gram-positive bacilli11.1%10.4%9.9% (6.9% to 13.5%)<0.0001†89.6%0.11 (−0.01 to 0.23)0.79
Streptococcus 16.7%5.8%3.3% (0.9% to 5.6%)0.006794.2%0.76 (0.66 to 0.85)0.88
Enterococcus (excluding VRE)14.9%10.1%7.1% (4.0% to 10.1%)<0.000189.9%0.44 (0.30 to 0.58)0.80
Coagulase-negative Staphylococcus 12.2%10.1%9.6% (6.7% to 12.9%)<0.0001†89.9%0.26 (0.11 to 0.41)0.80
Corynebacterium 9.4%8.6%8.1% (5.4% to 11.2%)<0.0001†91.4%0.13 (−0.01 to 0.28)0.83
Pseudomonas aeruginosa 8.6%4.1%0.0% (−2.0% to 2.0%)1.000095.9%0.67 (0.52 to 0.82)0.92
Staphylococcusaureus (excluding MRSA)35.7%8.1%0.0% (−2.8% to 2.8%)1.000091.9%0.81 (0.75 to 0.87)0.84
  • *Tissue-swab.

  • †Exact P value/CI.

  • MRSA, methicillin-resistant Staphylococcus aureus; PABAK, prevalence and bias-adjusted kappa; VRE, vancomycin-resistant Enterococcus.